Wei Wang, PhD

Dr. Wei Wang has nearly 20 years of experience in small-molecule and peptide drug research across oncology and autoimmune diseases. His expertise includes tumor biomarker analysis, in vitro pharmacology, and peptide-based therapeutic screening. He has published more than 30 scientific papers and contributed to multiple preclinical development programs.

▪ 20 years of drug discovery experience

▪ Expertise in tumor biomarkers, in vitro pharmacology, peptide screening

▪ 30+ scientific publications and book chapters

▪ Ph.D., Tokyo Metropolitan University

▪ Postdoctoral Fellow, RIKEN